Fig. 1From: Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysisThe frequency of reported mutations per group of ART drugs from 2003 to 2016. The number of new mutations reported for every drug in the three major ART groups, NNRTI’s (non-nucleoside reverse transcriptase inhibitors), NRTI’s (Reverse transcriptase inhibitors) and PI’s (Protease inhibitors) was combined and plottedBack to article page